Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Salmeterol compared with current therapies in chronic asthma

A D Adinoff1, H J Schwartz, K A Rickard

  • 1Colorado Allergy and Asthma Centers, Littleton 80122, USA.

The Journal of Family Practice
|October 28, 1998
PubMed
Summary

Long-term use of salmeterol, an inhaled beta 2-adrenergic agonist, safely improves persistent asthma control and lung function, even when reducing other asthma medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating treatment response to mepolizumab in patients with severe CRSwNP.

Rhinology·2023
Same author

Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment.

Allergy·2016
Same author

Investigations into traditionally managed Djallonké-sheep production in the humid and subhumid zones of Asante, Ghana: II. Reproductive events and prolificacy(1).

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2011
Same author

Analysis of reptilase and thrombin-induced changes in fibrinogen subunits by isoelectric focussing.

Thrombosis research·2010

Area of Science:

  • Pulmonology
  • Pharmacology
  • Clinical Medicine

Background:

  • Persistent asthma management often involves multiple therapies.
  • Long-term studies comparing salmeterol with existing combination regimens are limited.
  • Salmeterol is a selective, long-acting inhaled beta 2-adrenergic agonist.

Purpose of the Study:

  • To evaluate the long-term efficacy and safety of salmeterol in persistent asthma.
  • To compare salmeterol treatment with placebo, with or without weaning of other asthma therapies.
  • To assess the impact of salmeterol on pulmonary function and asthma symptoms.

Main Methods:

  • A multicenter, randomized, double-blind, placebo-controlled study.
  • 386 patients with persistent asthma were randomized to salmeterol or placebo.

Related Experiment Videos

  • Patients were further randomized to wean or not wean from current non-corticosteroid asthma therapies.

    • Main Results:

    • Salmeterol significantly improved morning peak expiratory flow rate compared to placebo, even with medication weaning.
    • Patients receiving salmeterol showed significant improvements in asthma symptom scores and reduced albuterol use.
    • No significant safety differences were observed between salmeterol and placebo groups.

    Conclusions:

    • Adding salmeterol to persistent asthma treatment provides sustained improvements in lung function and symptoms.
    • Long-term salmeterol use is safe and enhances asthma stability during reductions in other therapies.
    • Salmeterol offers a valuable therapeutic option for managing persistent asthma.